vs
iQSTEL Inc（IQST）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
iQSTEL Inc的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$84.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -14.9%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-1.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 28.0%）
iQSTEL Inc是一家科技控股企业，业务覆盖电信、物联网与金融科技三大核心领域，面向南北美洲市场的中小企业及零售用户提供高性价比的通信服务、智能物联网监测解决方案及数字化金融工具。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
IQST vs PBYI — 直观对比
营收规模更大
IQST
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出42.6%
-14.9%
自由现金流更多
PBYI
多$15.6M
$-1.2M
两年增速更快
PBYI
近两年复合增速
28.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $84.2M | $75.5M |
| 净利润 | $-2.7M | — |
| 毛利率 | 3.5% | 69.3% |
| 营业利润率 | -2.9% | 22.7% |
| 净利率 | -3.2% | — |
| 营收同比 | -14.9% | 27.7% |
| 净利润同比 | -44.5% | — |
| 每股收益（稀释后） | $-0.92 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IQSTPBYI
| Q4 25 | $84.2M | $75.5M | ||
| Q3 25 | $102.9M | $54.5M | ||
| Q2 25 | $72.2M | $52.4M | ||
| Q1 25 | $57.6M | $46.0M | ||
| Q4 24 | $98.9M | $59.1M | ||
| Q3 24 | $54.2M | $80.5M | ||
| Q2 24 | $78.6M | $47.1M | ||
| Q1 24 | $51.4M | $43.8M |
净利润IQSTPBYI
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.3M | $8.8M | ||
| Q2 25 | $-2.3M | $5.9M | ||
| Q1 25 | $-1.1M | $3.0M | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-773.0K | $20.3M | ||
| Q2 24 | $-2.0M | $-4.5M | ||
| Q1 24 | $-580.2K | $-4.8M |
毛利率IQSTPBYI
| Q4 25 | 3.5% | 69.3% | ||
| Q3 25 | 2.7% | 77.7% | ||
| Q2 25 | 2.6% | 76.5% | ||
| Q1 25 | 3.4% | 77.1% | ||
| Q4 24 | 2.7% | 76.4% | ||
| Q3 24 | 3.7% | 63.9% | ||
| Q2 24 | 2.8% | 77.4% | ||
| Q1 24 | 2.7% | 75.5% |
营业利润率IQSTPBYI
| Q4 25 | -2.9% | 22.7% | ||
| Q3 25 | -0.5% | 17.6% | ||
| Q2 25 | -0.9% | 12.7% | ||
| Q1 25 | -1.0% | 8.7% | ||
| Q4 24 | -0.3% | 22.6% | ||
| Q3 24 | -0.1% | 27.4% | ||
| Q2 24 | -0.4% | -4.6% | ||
| Q1 24 | -0.4% | -5.3% |
净利率IQSTPBYI
| Q4 25 | -3.2% | — | ||
| Q3 25 | -2.3% | 16.2% | ||
| Q2 25 | -3.3% | 11.2% | ||
| Q1 25 | -2.0% | 6.5% | ||
| Q4 24 | -1.9% | — | ||
| Q3 24 | -1.4% | 25.2% | ||
| Q2 24 | -2.5% | -9.6% | ||
| Q1 24 | -1.1% | -11.0% |
每股收益（稀释后）IQSTPBYI
| Q4 25 | $-0.92 | $0.26 | ||
| Q3 25 | $-0.68 | $0.17 | ||
| Q2 25 | $-0.82 | $0.12 | ||
| Q1 25 | $-0.44 | $0.06 | ||
| Q4 24 | $-1.19 | $0.40 | ||
| Q3 24 | $-0.40 | $0.41 | ||
| Q2 24 | $-0.90 | $-0.09 | ||
| Q1 24 | $-0.37 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2M | $97.5M |
| 总债务越低越好 | $4.1M | $22.7M |
| 股东权益账面价值 | $16.3M | $130.3M |
| 总资产 | $51.1M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资IQSTPBYI
| Q4 25 | $2.2M | $97.5M | ||
| Q3 25 | $2.3M | $94.4M | ||
| Q2 25 | $2.0M | $96.0M | ||
| Q1 25 | $1.1M | $93.2M | ||
| Q4 24 | $2.5M | $101.0M | ||
| Q3 24 | $2.1M | $96.7M | ||
| Q2 24 | $797.2K | $96.8M | ||
| Q1 24 | $2.7M | $107.2M |
总债务IQSTPBYI
| Q4 25 | $4.1M | $22.7M | ||
| Q3 25 | $2.7M | $34.0M | ||
| Q2 25 | $4.5M | $45.3M | ||
| Q1 25 | $3.5M | $56.7M | ||
| Q4 24 | $2.5M | $68.0M | ||
| Q3 24 | $3.2M | $79.3M | ||
| Q2 24 | $2.5M | $90.7M | ||
| Q1 24 | $194.0K | $102.0M |
股东权益IQSTPBYI
| Q4 25 | $16.3M | $130.3M | ||
| Q3 25 | $17.9M | $115.3M | ||
| Q2 25 | $14.3M | $104.7M | ||
| Q1 25 | $11.6M | $97.1M | ||
| Q4 24 | $11.9M | $92.1M | ||
| Q3 24 | $8.1M | $71.1M | ||
| Q2 24 | $7.6M | $48.5M | ||
| Q1 24 | $8.4M | $51.0M |
总资产IQSTPBYI
| Q4 25 | $51.1M | $216.3M | ||
| Q3 25 | $46.9M | $202.9M | ||
| Q2 25 | $51.4M | $194.9M | ||
| Q1 25 | $42.0M | $196.2M | ||
| Q4 24 | $79.0M | $213.3M | ||
| Q3 24 | $32.4M | $220.7M | ||
| Q2 24 | $30.0M | $205.0M | ||
| Q1 24 | $22.1M | $214.1M |
负债/权益比IQSTPBYI
| Q4 25 | 0.25× | 0.17× | ||
| Q3 25 | 0.15× | 0.30× | ||
| Q2 25 | 0.31× | 0.43× | ||
| Q1 25 | 0.31× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.40× | 1.12× | ||
| Q2 24 | 0.34× | 1.87× | ||
| Q1 24 | 0.02× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -1.5% | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.0M | $41.7M |
8季度趋势，按日历期对齐
经营现金流IQSTPBYI
| Q4 25 | $-1.2M | $14.4M | ||
| Q3 25 | $-953.0K | $9.7M | ||
| Q2 25 | $257.7K | $14.1M | ||
| Q1 25 | $-1.9M | $3.6M | ||
| Q4 24 | $-403.7K | $15.6M | ||
| Q3 24 | $625.0K | $11.0M | ||
| Q2 24 | $-2.6M | $1.0M | ||
| Q1 24 | $-536.9K | $11.2M |
自由现金流IQSTPBYI
| Q4 25 | $-1.2M | $14.4M | ||
| Q3 25 | $-969.2K | $9.7M | ||
| Q2 25 | $211.7K | $14.1M | ||
| Q1 25 | $-2.0M | $3.6M | ||
| Q4 24 | $-421.3K | $15.6M | ||
| Q3 24 | $594.5K | $11.0M | ||
| Q2 24 | $-2.6M | $1.0M | ||
| Q1 24 | $-608.5K | — |
自由现金流率IQSTPBYI
| Q4 25 | -1.5% | 19.1% | ||
| Q3 25 | -0.9% | 17.7% | ||
| Q2 25 | 0.3% | 26.8% | ||
| Q1 25 | -3.4% | 7.7% | ||
| Q4 24 | -0.4% | 26.4% | ||
| Q3 24 | 1.1% | 13.7% | ||
| Q2 24 | -3.4% | 2.1% | ||
| Q1 24 | -1.2% | — |
资本支出强度IQSTPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率IQSTPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IQST
| USA | $53.2M | 63% |
| Other | $29.9M | 35% |
| Switzerland | $1.1M | 1% |
PBYI
暂无分部数据
